Sherwin-Williams (NYSE:SHW) PT Set at $600.00 by Morgan Stanley

Sherwin-Williams (NYSE:SHW) has been assigned a $600.00 target price by investment analysts at Morgan Stanley in a report issued on Monday, TipRanks reports. The brokerage currently has a “buy” rating on the specialty chemicals company’s stock. Morgan Stanley’s target price suggests a potential upside of 16.45% from the stock’s previous close.

SHW has been the subject of a number of other reports. Royal Bank of Canada increased their target price on Sherwin-Williams to $550.00 and gave the stock an “outperform” rating in a research note on Thursday, July 25th. Northcoast Research reissued a “neutral” rating on shares of Sherwin-Williams in a research note on Monday, July 29th. Robert W. Baird increased their target price on Sherwin-Williams from $480.00 to $525.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. JPMorgan Chase & Co. increased their target price on Sherwin-Williams from $435.00 to $490.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. Finally, Buckingham Research increased their target price on Sherwin-Williams from $440.00 to $460.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 24th. Nine equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Sherwin-Williams has a consensus rating of “Buy” and a consensus target price of $518.63.

NYSE SHW traded down $10.60 during trading hours on Monday, reaching $515.25. 17,109 shares of the company’s stock were exchanged, compared to its average volume of 604,521. The business’s 50-day moving average price is $483.77. Sherwin-Williams has a one year low of $355.28 and a one year high of $527.00. The company has a debt-to-equity ratio of 2.29, a current ratio of 0.80 and a quick ratio of 0.50. The firm has a market capitalization of $47.95 billion, a P/E ratio of 27.99, a price-to-earnings-growth ratio of 2.04 and a beta of 1.28.



Sherwin-Williams (NYSE:SHW) last posted its earnings results on Tuesday, July 23rd. The specialty chemicals company reported $6.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.35 by $0.22. Sherwin-Williams had a return on equity of 48.92% and a net margin of 6.61%. The business had revenue of $4.88 billion during the quarter, compared to analysts’ expectations of $4.94 billion. During the same period in the prior year, the business earned $5.73 EPS. Sherwin-Williams’s revenue for the quarter was up 2.2% compared to the same quarter last year. Analysts predict that Sherwin-Williams will post 21.1 EPS for the current year.

In other news, Director David F. Hodnik sold 501 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $521.57, for a total value of $261,306.57. Following the completion of the sale, the director now owns 9,569 shares of the company’s stock, valued at approximately $4,990,903.33. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Jane M. Cronin sold 1,627 shares of the stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $515.00, for a total value of $837,905.00. Following the completion of the sale, the senior vice president now directly owns 3,598 shares of the company’s stock, valued at approximately $1,852,970. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 31,608 shares of company stock valued at $15,329,391. Insiders own 0.50% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SHW. OZ Management LP boosted its holdings in shares of Sherwin-Williams by 98.2% in the 1st quarter. OZ Management LP now owns 595,512 shares of the specialty chemicals company’s stock valued at $256,493,000 after buying an additional 294,988 shares during the last quarter. Meritage Group LP boosted its holdings in shares of Sherwin-Williams by 11.7% in the 1st quarter. Meritage Group LP now owns 985,589 shares of the specialty chemicals company’s stock valued at $424,503,000 after buying an additional 103,486 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Sherwin-Williams by 1.7% in the 2nd quarter. BlackRock Inc. now owns 5,530,261 shares of the specialty chemicals company’s stock valued at $2,534,464,000 after buying an additional 90,828 shares during the last quarter. Marshall Wace North America L.P. boosted its holdings in shares of Sherwin-Williams by 93.8% in the 1st quarter. Marshall Wace North America L.P. now owns 174,765 shares of the specialty chemicals company’s stock valued at $75,274,000 after buying an additional 84,610 shares during the last quarter. Finally, Farallon Capital Management LLC lifted its holdings in Sherwin-Williams by 21.2% during the 2nd quarter. Farallon Capital Management LLC now owns 465,699 shares of the specialty chemicals company’s stock valued at $213,425,000 after purchasing an additional 81,536 shares during the last quarter. 76.05% of the stock is owned by institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers. It operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group. The Americas Group segment offers architectural paints and coatings, and protective and marine products, as well as OEM product finishes and related products for architectural and industrial paint contractors and do-it-yourself homeowners.

Read More: Insider Trading – What You Need to Know

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.